Specific combinations of biallelic variants cause Wiedemann-Rautenstrauch syndrome.

Gabriele Gillessen-Kaesbach, Raoul C Hennekam, Marco Tartaglia, Bernd Wollnik, Carlos Lopez-Otin, Humberto Arboleda, Gökhan Yigit, Gloria Velasco, Adrian Sandoval, Jenny Ortega, Antonio Novelli, Christian Müller, Shehla Mohammed, Thomas Krieg, Stefano Paolacci, Andrea Ciolfi, Alessandro Bruselles, Filippo Beleggia, Gonzalo Arboleda, Janine Altmüller, Mariel Alders, Lihadh Al-Gazali, Debora Bertola, Dido Carrero, Carlos E Arboleda-Bustos, Emanuele Bellacchio, Emanuele Agolini, Yun Li

Journal: Journal of medical genetics 2019;55(12):837-846

PMID: 30323018

Abstract

BACKGROUND

Wiedemann-Rautenstrauch syndrome (WRS) is a form of segmental progeria presenting neonatally, characterised by growth retardation, sparse scalp hair, generalised lipodystrophy with characteristic local fatty tissue accumulations and unusual face. We aimed to understand its molecular cause.

METHODS

We performed exome sequencing in two families, targeted sequencing in 10 other families and performed in silico modelling studies and transcript processing analyses to explore the structural and functional consequences of the identified variants.

RESULTS

Biallelic variants were identified in eight affected individuals and monoallelic variants of the same gene in four other individuals. In the latter, lack of genetic material precluded further analyses. Multiple variants were found to affect transcript processing and were mostly located in deep intronic regions, making clinical suspicion fundamental to detection. While biallelic variants have been previously reported in 4H syndrome and adolescent-onset progressive spastic ataxia, recurrent haplotypes specifically occurring in individuals with WRS were detected. All WRS-associated POLR3A amino acid changes were predicted to perturb substantially POLR3A structure/function.

CONCLUSION

Biallelic mutations in , which encodes for the largest subunit of the DNA-dependent RNA polymerase III, underlie WRS. No isolated functional sites in POLR3A explain the phenotype variability in POLR3A-related disorders. We suggest that specific combinations of compound heterozygous variants must be present to cause the WRS phenotype. Our findings expand the molecular mechanisms contributing to progeroid disorders.

© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Address: Department of Experimental Medicine, Sapienza "University of Rome", Rome, Italy.; Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.; Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Roma, Italy.; Neuroscience and Cell Death Group, Faculty of Medicine and Institute of Genetics, Universidad Nacional de Colombia, Bogota, Colombia.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, and Centro de Investigación Biomédica en Red de Cáncer, Oviedo, Spain.; Unidade de Genética do Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, e Centro de Estudos sobre o Genoma Humano e Células-Tronco do Instituto de Biociências da Universidade de São Paulo, São Paulo, Brazil.; Department of Paediatric, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates.; Department of Clinical Genetics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.; Cologne Centre for Genomics and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.; Dipartimento di Oncologia e Medicina Molecolare, Istituto Superiore di Sanità, Rome, Italy.; Institute of Human Genetics, University of Lübeck, Lübeck, Germany.; Department of Dermatology, University Hospital Cologne, Cologne, Germany.; Department of Clinical Genetics, Guy's Hospital, London, UK.; Department of Paediatrics, Amsterdam UMC - location AMC, University of Amsterdam, Amsterdam, The Netherlands.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.